Serotonin transporter gene polymorphisms in patients with chronic tension-type headache: A preliminary study
Background and Objectives: This study is designed to understand the pathophysiology of one of the most serious health problems, chronic tension-type headache (CTTH). Two polymorphic sites in serotonin transporter protein gene attracted much interest. These are: the variable number of tandem repeats...
Gespeichert in:
Veröffentlicht in: | Neurology India 2008-04, Vol.56 (2), p.156-160 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background and Objectives: This study is designed to understand the
pathophysiology of one of the most serious health problems, chronic
tension-type headache (CTTH). Two polymorphic sites in serotonin
transporter protein gene attracted much interest. These are: the
variable number of tandem repeats (VNTR) and 5′-flanking promoter
region (5-HTTLPR). Materials and Methods: VNTR and 5-HTTLPR
polymorphisms were investigated in 126 CTTH patients and 138 healthy
control subjects. The patients were being treated with amitripytyline
or citalopram or sertraline (SSRI). The polymerase chain reaction (PCR)
method was used to investigate the polymorphisms in the serotonin
transporter protein gene. Results: There were no statistically
significant results based on the 5-HTTLPR gene alleles, however, STin
2.12/12 genotype and STin 2.12 allele were seen to predominate the
control group. In order to investigate the combined effect of the two
polymorphic loci on the 5-HTT gene expression, samples were separated
into nine groups. Genotypes (S/S-12/10) and (L/S-12/10) displayed
statistically significant frequency in the CTTH group than in the
control group. No significant differences were noticed between the
5-HTTLPR and VNTR haplotype groups and success in treatment.
Conclusion: It is possible to make reliable comparisons and hypothesis
about the homozygous and/or heterozygous presence of S and STin 12/10
alleles which may be in interaction with CTTH. On the other hand, the
presence of homozygous L and STin12 alleles may play a protective role
against CTTH. It is also possible that heterogeneity among diseases
showing the same clinical research will require a lot of effort for
individual identification. |
---|---|
ISSN: | 0028-3886 1998-4022 |
DOI: | 10.4103/0028-3886.41993 |